Pharmaceutical Grade Mycophenolate Mofetil USP from Japan
Mycophenolate mofetil meeting United States Pharmacopeia (USP) standards for use in FDA-approved generic drug manufacturing. This specific aromatic heterocyclic immunosuppressant falls under HTS 2934.99.01.00 per Chapter 29 notes for chemically defined organic compounds. The product's fused ring system with ester functionality defines its precise tariff classification.
Duty Rate — Japan → United States
27.5%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include USP Certificate of Analysis with batch-specific impurity profiles (mycophenolic acid <0.5%, impurities <0.1%)
• Use temperature-controlled shipping (2-8°C) and declare controlled temperature on commercial invoice to avoid rejection
• Register with FDA's Drug Establishment Registration system before first import of this API